LetterLetter
Dabigatran
L. Murphy, L. Lawler and E.C. Kavanagh
American Journal of Neuroradiology November 2011, 32 (10) E195; DOI: https://doi.org/10.3174/ajnr.A2850
L. Murphy
L. Lawler

References
- 1.↵
European Medicines. Pradaxa, dabigatran etexilate. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000829/human_med_000981.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124. Accessed July 20, 2011
- 2.↵
- Eriksson BI,
- Friedman RJ
- 3.↵
European Medicines Agency. Committee for Medicinal Products for Human Use. Summary of positive opinion (post-authorisation) for Pradaxa, dabigatran etexilate mesilate. http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/000829/WC500105283.pdf. Accessed July 21, 2011
- 4.↵
Boehringer Ingelheim GmbH. Pradaxa, dabigatran etexilate. Guide for surgery and interventions. http://global.pradaxa.com/surgery-and-interventions/prescriber-guide.html?width=&height=. Accessed July 20, 2011
In this issue
Advertisement
L. Murphy, L. Lawler, E.C. Kavanagh
Dabigatran
American Journal of Neuroradiology Nov 2011, 32 (10) E195; DOI: 10.3174/ajnr.A2850
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement